Related references
Note: Only part of the references are listed.Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
Ivo G. Schoots et al.
WORLD JOURNAL OF UROLOGY (2020)
Genetic Markers in Lung Cancer Diagnosis: A Review
Katarzyna Wadowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 30, pg 128, 2019)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer
Xiaofen Zhang et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Breath analysis of cancer in the present and the future
Reef Einoch Amor et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors
Yoav Y. Broza et al.
CHEMICAL REVIEWS (2019)
Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
Fabienne Schochter et al.
CELLS (2019)
CTCs Expression Profiling for Advanced Breast Cancer Monitoring
Thais Pereira-Veiga et al.
CANCERS (2019)
Profiling Single Cancer Cells with Volatolomics Approach
Mamatha Serasanambati et al.
ISCIENCE (2019)
Clinical indications for, and the future of, circulating tumor cells
Dominic H. Moon et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
A study on volatile organic compounds emitted by in-vitro lung cancer cultured cells using gas sensor array and SPME-GCMS
Reena Thriumani et al.
BMC CANCER (2018)
Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation
Yoav Y. Broza et al.
CHEMICAL SOCIETY REVIEWS (2018)
The identification and isolation of CTCs: A biological Rubik's cube
Cristina Mansilla et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Breast cancer diagnosis: Imaging techniques and biochemical markers
Seyed Hamed Jafari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers
Giuseppe Lubes et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
Jillian Wilhelmina Paulina Bracht et al.
CURRENT ONCOLOGY REPORTS (2018)
Advances in liquid biopsy approaches for early detection and monitoring of cancer
Anna Babayan et al.
GENOME MEDICINE (2018)
Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
Minji Lim et al.
MICROMACHINES (2018)
The Significance of Liquid Biopsy in Pancreatic Cancer
Zi-Hao Qi et al.
JOURNAL OF CANCER (2018)
Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications
Dibyendu Dutta et al.
JOURNAL OF BREATH RESEARCH (2018)
The growing role of precision and personalized medicine for cancer treatment
Paulina Krzyszczyk et al.
TECHNOLOGY (2018)
Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules
Morad K. Nakhleh et al.
ACS NANO (2017)
Molecular Imaging and Oral Cancer Diagnosis and Therapy
Maryam Keshavarzi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
The Effect of Breast Cancer Fear Levels of Female Seasonal Agricultural Laborers on Early-Diagnosis Behaviors and Perceptions of Breast Cancer
Perihan Polat et al.
SOCIAL WORK IN PUBLIC HEALTH (2017)
Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
Yilin Li et al.
BRITISH JOURNAL OF CANCER (2016)
The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer (vol 95, pg e4392, 2016)
T. W. Yen et al.
MEDICINE (2016)
Limits to Personalized Cancer Medicine
Ian F. Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Technical challenges in the isolation and analysis of circulating tumor cells
Emma E. van der Toom et al.
ONCOTARGET (2016)
Selectivity and Specificity: Pros and Cons in Sensing
William J. Peveler et al.
ACS SENSORS (2016)
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples
Priya Gogoi et al.
PLOS ONE (2016)
Hybrid Volatolomics and Disease Detection
Yoav Y. Broza et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility
Michail Ignatiadis et al.
CLINICAL CANCER RESEARCH (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
The Utility and Limitations of Contrast-Enhanced Ultrasound for the Diagnosis and Treatment of Prostate Cancer
Futoshi Sano et al.
SENSORS (2015)
Nanoscale Sensor Technologies for Disease Detection via Volatolomics
Rotem Vishinkin et al.
SMALL (2015)
Tracking Viable Circulating Tumor Cells (CTCs) in the Peripheral Blood of Non-Small Cell Lung Cancer (NSCLC) Patients Undergoing Definitive Radiation Therapy: Pilot Study Results
Jay F. Dorsey et al.
CANCER (2015)
Biology, detection, and clinical implications of circulating tumor cells
Simon A. Joosse et al.
EMBO MOLECULAR MEDICINE (2015)
Urinary Volatile Organic Compounds for the Detection of Prostate Cancer
Tanzeela Khalid et al.
PLOS ONE (2015)
Sensors for Breath Testing: From Nanomaterials to Comprehensive Disease Detection
Gady Konvalina et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Monolayer-capped gold nanoparticles for disease detection from breath
Morad K. Nakhleh et al.
NANOMEDICINE (2014)
Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis
Lu Han et al.
TUMOR BIOLOGY (2014)
The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva
Anton Amann et al.
JOURNAL OF BREATH RESEARCH (2014)
Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties
Anton Amann et al.
JOURNAL OF BREATH RESEARCH (2014)
Combined Volatolomics for Monitoring of Human Body Chemistry
Yoav Y. Broza et al.
SCIENTIFIC REPORTS (2014)
Nanomaterial-based sensors for detection of disease by volatile organic compounds
Yoav Y. Broza et al.
NANOMEDICINE (2013)
Volatile fingerprints of cancer specific genetic mutations
Nir Peled et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
T. J. N. Hiltermann et al.
ANNALS OF ONCOLOGY (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Liling Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Challenges in the Enumeration and Phenotyping of CTC
Frank A. W. Coumans et al.
CLINICAL CANCER RESEARCH (2012)
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)
Haitham Amal et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Beyond counting tumor cells
Jim Kling
NATURE BIOTECHNOLOGY (2012)
Classification of breast cancer precursors through exhaled breath
Gregory Shuster et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Diagnosis of head-and-neck cancer from exhaled breath
M. Hakim et al.
BRITISH JOURNAL OF CANCER (2011)
Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
Anja van de Stolpe et al.
CANCER RESEARCH (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano et al.
BREAST CANCER RESEARCH (2011)
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors
G. Peng et al.
BRITISH JOURNAL OF CANCER (2010)
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Todd M. Morgan et al.
CLINICAL CANCER RESEARCH (2009)
Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
Sze Chuen Cesar Wong et al.
CLINICAL CANCER RESEARCH (2009)
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
Tina Fan et al.
GYNECOLOGIC ONCOLOGY (2009)
Detection of Nonpolar Molecules by Means of Carrier Scattering in Random Networks of Carbon Nanotubes: Toward Diagnosis of Diseases via Breath Samples
Gang Peng et al.
NANO LETTERS (2009)
Diagnosing lung cancer in exhaled breath using gold nanoparticles
Gang Peng et al.
NATURE NANOTECHNOLOGY (2009)
Sniffing the Unique Odor Print of Non-Small-Cell Lung Cancer with Gold Nanoparticles
Orna Barash et al.
SMALL (2009)
Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection
Yih-Huei Uen et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse
Katharina Pachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detecting Simulated Patterns of Lung Cancer Biomarkers by Random Network of Single-Walled Carbon Nanotubes Coated with Nonpolymeric Organic Materials
Gang Peng et al.
NANO LETTERS (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
PSA and new biomarkers within multivariate models to improve early detection of prostate cancer
Carsten Stephan et al.
CANCER LETTERS (2007)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer
A Paz et al.
NUCLEAR MEDICINE COMMUNICATIONS (2000)
Share Paper
